Physician profile
Christopher J Mutrie
NPI 1679757157
$9,626.69
in general payments reported to CMS, 2019-2025
10 companies · $7,880 in 2025
The $7,880 reported for 2025 was more than what 87% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.45 · 2020: $657 · 2022: $201 · 2023: $442 · 2024: $408 · 2025: $7,880.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $5,250 · Food and Beverage: $2,150 · Travel and Lodging: $1,330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $5,250.00 |
| Food and Beverage | $2,149.57 |
| Travel and Lodging | $1,329.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $7,542.68 | 2020-2025 | Arista, Progel Applicator Spray Tips, Arista Ah Flexitip |
| Intuitive Surgical, INC. | $774.45 | 2025 | |
| Zimmer Biomet Holdings, INC. | $596.48 | 2020 | |
| Ethicon US, LLC | $403.68 | 2023 | Surgicel Nu-Knit, Dermabond, Prolene |
| Becton, Dickinson and Company | $85.00 | 2024 | Arista Ah Flexitip |
| Atricure, INC. | $68.87 | 2022 | |
| Genentech USA, INC. | $63.33 | 2022 | |
| Bard Access Systems, INC. | $39.45 | 2019 | |
| Edwards Lifesciences Corporation | $38.07 | 2023 | |
| Nuwellis, INC. | $14.68 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Mutrie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.